StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) operating KPIs

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)

Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%

Abbott Laboratories u.S. States Where Abbott Holds WIC Infant Formula Contracts (States)

Form 10-K MD&A ('Critical Accounting Policies — Sales Rebates: At December 31, Abbott had WIC business in X states')

Latest, FY2024
42
Period ended Dec 31, 2024
Change on a year earlier
+5.0%
40 in FY2023
History
12 years
Since FY2013
Sources
12
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedU.S. States Where Abbott Holds WIC Infant Formula Contracts (States)Year on yearSource
FY2024Dec 31, 202442+5.0%SEC Filing (0001628280-25-007110) ↗
FY2023Dec 31, 202340+8.1%SEC Filing (0001628280-24-005348) ↗
FY2022Dec 31, 202237+2.8%SEC Filing (0001628280-23-004026) ↗
FY2021Dec 31, 202136+33.3%SEC Filing (0001104659-22-025141) ↗
FY2020Dec 31, 202027+3.8%SEC Filing (0001104659-21-025751) ↗
FY2019Dec 31, 201926-3.7%SEC Filing (0001104659-20-023904) ↗
FY2018Dec 31, 201827-6.9%SEC Filing (0001047469-19-000624) ↗
FY2017Dec 31, 201729-6.5%SEC Filing (0001047469-18-000856) ↗
FY2016Dec 31, 201631+19.2%SEC Filing (0001047469-17-000744) ↗
FY2015Dec 31, 201526+13.0%SEC Filing (0001047469-16-010246) ↗
FY2014Dec 31, 2014230.0%SEC Filing (0001047469-15-001377) ↗
FY2013Dec 31, 201323–SEC Filing (0001047469-14-001176) ↗

Cite this data

StockData. (2026). Abbott Laboratories U.S. States Where Abbott Holds WIC Infant Formula Contracts (States), annual FY2013–FY2024 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/ped-wic-states

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.